HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anti-endotoxin hyperimmune globulin attenuates portal cytokinaemia, phagocytic cell priming, and acute lung injury after lower limb ischaemia-reperfusion injury.

AbstractOBJECTIVES:
Acute limb ischaemia is a common and often lethal clinical event. Reperfusion of an ischaemic limb has been shown to induce a remote gut injury associated with transmigration of endotoxin into the portal and systemic circulation, which in turn has been implicated in the conversion of the sterile inflammatory response to a sepsis syndrome, after lower torso ischaemia-reperfusion injury. This study tests the hypothesis that an anti-endotoxin hyperimmune globulin attenuates ischaemia-reperfusion (I/R) associated sepsis syndrome.
DESIGN:
Prospective, randomised placebo controlled trial, animal experiment.
MATERIALS AND METHODS:
Experimental porcine model, bilateral hind limb I/R injury, randomised to receive anti-endotoxin hyperimmune globulin or placebo.
RESULTS:
Bilateral hind limb I/R injury significantly increased intestinal mucosal acidosis, portal endotoxaemia, plasma cytokine (TNF-alpha, IL-6, IL-8) concentrations, circulating phagocytic cell priming and pulmonary leukosequestration, oedema, and capillary-alveolar protein leak. Conversely, pigs treated with anti-endotoxin hyperimmune globulin (IgG) 20mg/kg at onset of reperfusion had significantly reduced portal endotoxaemia, early circulating phagocytic cell priming, plasma cytokinaemia and attenuation of acute lung injury.
CONCLUSIONS:
Endotoxin translocation across a hyperpermeable gut barrier, phagocytic cell priming and cytokinaemia are key events of limb I/R injury induced systemic inflammation and acute lung injury. This study shows that an anti-endotoxin hyperimmune globulin attenuates portal endotoxaemia, which may reduce early phagocytic cell activation, cytokinaemia and ultimately acute lung injury.
AuthorsD W Harkin, R Arnold, M Hoper
JournalEuropean journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery (Eur J Vasc Endovasc Surg) Vol. 33 Issue 3 Pg. 330-9 (Mar 2007) ISSN: 1078-5884 [Print] England
PMID17161961 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cytokines
  • Endotoxins
  • Immunoglobulin G
  • Immunoglobulins
  • Tumor Necrosis Factor-alpha
  • antilipopolysaccharide antibodies
  • Oxygen
Topics
  • Animals
  • Bacterial Translocation (immunology)
  • Cytokines
  • Disease Models, Animal
  • Endotoxins (chemistry)
  • Hindlimb (blood supply)
  • Immunoglobulin G (pharmacology)
  • Immunoglobulins (pharmacology)
  • Luminescent Measurements
  • Male
  • Manometry
  • Oxygen (blood)
  • Partial Pressure
  • Phagocytosis (drug effects, immunology)
  • Portal System (immunology)
  • Portal Vein (chemistry)
  • Prospective Studies
  • Random Allocation
  • Reperfusion Injury (immunology)
  • Respiratory Burst (immunology)
  • Respiratory Distress Syndrome (immunology)
  • Swine
  • Tumor Necrosis Factor-alpha (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: